2+ hour, 52+ min ago  (147+ words) PA Media Chemify Launches the World's First Chemputation Facility Revolutionizing Molecular Design and Manufacture Chemify Receives an Additional Grant to Accelerate Digital Chemistry Small-Molecule Discovery for Tuberculosis Chemify Raises More Than $50 Million in Oversubscribed Series B to Drive Global Expansion…...

1+ hour, 26+ min ago  (97+ words) Eurek Alert! The core innovation of this work lies in the clever exploitation of noncovalent interactions. Through a conformational restriction strategy, the molecular spatial geometry is precisely controlled while hydrogen'bond donors that could adversely affect physicochemical properties are effectively masked....

2+ hour, 58+ min ago  (216+ words) PR News | 09 abr, 2026 WILMINGTON, Del. and COPENHAGEN, Denmark, April 9, 2026 /PRNewswire/ -- Deep Cyte, a techbio company building AI toxicology tools for drug development, launched today with $1. 5 million in seed funding. The company is introducing two solutions to help biopharma teams detect,…...

10+ hour, 8+ min ago  (242+ words) Scripps Research chemists solve a longstanding problem in the construction of branched molecular frameworks, unlocking a faster path to the complex structures found in drugs and materials. "This work solves a selectivity problem that challenged us for years," says Ryan…...

4+ hour, 42+ min ago  (68+ words) open PR. com Top Players and Competitive Overview in the Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Press release from: The Business Research Company Permanent link to this press release: You can edit or delete your press release Top…...

6+ hour, 58+ min ago  (633+ words) TAMPA" In the race to limit brain damage after a stroke, most treatments try to block harmful processes. According to a news release, a University of Florida Health researcher is pursuing a different strategy: boosting the brain's own protective machinery....

4+ hour, 5+ min ago  (7+ words) AI-Designed Artificial Protein Targets Disease Substances...

1+ day, 1+ hour ago  (177+ words) For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms The study found that'antibody therapeutics with stronger binding affinity to Fc" receptors on immune cells were significantly more likely to induce…...

11+ hour, 25+ min ago  (236+ words) Text | Hu Xiangyun Editor | Hai Ruojing The pharmaceutical industry is one step closer to "saying goodbye" to animal testing. Image source: FDA official website Previously, one of the major doubts about organoid/organ-on-a-chip companies in the pharmaceutical industry was whether…...

8+ hour, 28+ min ago  (283+ words) Artificial protein that recognizes the stress hormone cortisol enables a novel biosensor. A KAIST research team, in collaboration with the 2024 Nobel laureate in Chemistry, Professor David Baker of the University of Washington, has successfully used artificial intelligence (AI) to design,…...